Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 721 to 728 of 728 entries
Sorted by: Best Match Show Resources per page
Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial).

Chest

Papaioannou A, Kennedy CC, Freitag A, Ioannidis G, O'Neill J, Webber C, Pui M, Berthiaume Y, Rabin HR, Paterson N, Jeanneret A, Matouk E, Villeneuve J, Nixon M, Adachi JD.
PMID: 18641106
Chest. 2008 Oct;134(4):794-800. doi: 10.1378/chest.08-0608. Epub 2008 Jul 18.

BACKGROUND: Patients with cystic fibrosis (CF) are at risk for early bone loss, and demonstrate increased risks for vertebral fractures and kyphosis. A multicenter, randomized, controlled trial was conducted to assess the efficacy, tolerability, and safety of therapy with...

Cite
Papaioannou A, Kennedy CC, Freitag A, et al. Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial). Chest. 2008;134(4):794-800doi: 10.1378/chest.08-0608.
Papaioannou, A., Kennedy, C. C., Freitag, A., Ioannidis, G., O'Neill, J., Webber, C., Pui, M., Berthiaume, Y., Rabin, H. R., Paterson, N., Jeanneret, A., Matouk, E., Villeneuve, J., Nixon, M., & Adachi, J. D. (2008). Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial). Chest, 134(4), 794-800. https://doi.org/10.1378/chest.08-0608
Papaioannou, Alexandra, et al. "Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial)." Chest vol. 134,4 (2008): 794-800. doi: https://doi.org/10.1378/chest.08-0608
Papaioannou A, Kennedy CC, Freitag A, Ioannidis G, O'Neill J, Webber C, Pui M, Berthiaume Y, Rabin HR, Paterson N, Jeanneret A, Matouk E, Villeneuve J, Nixon M, Adachi JD. Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial). Chest. 2008 Oct;134(4):794-800. doi: 10.1378/chest.08-0608. Epub 2008 Jul 18. PMID: 18641106; PMCID: PMC5104558.
Copy Download .nbib Format: NLM
Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions.

Diabetes research and clinical practice

Stevens JW, Khunti K, Harvey R, Johnson M, Preston L, Woods HB, Davies M, Goyder E.
PMID: 25638454
Diabetes Res Clin Pract. 2015 Mar;107(3):320-31. doi: 10.1016/j.diabres.2015.01.027. Epub 2015 Jan 21.

AIMS: Individuals with impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) have an increased risk of progression to Type 2 diabetes mellitus. The objective of this review was to quantify the effectiveness of lifestyle, pharmacological and surgical interventions...

Cite
Stevens JW, Khunti K, Harvey R, et al. Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions. Diabetes Res Clin Pract. 2015;107(3):320-31doi: 10.1016/j.diabres.2015.01.027.
Stevens, J. W., Khunti, K., Harvey, R., Johnson, M., Preston, L., Woods, H. B., Davies, M., & Goyder, E. (2015). Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions. Diabetes research and clinical practice, 107(3), 320-31. https://doi.org/10.1016/j.diabres.2015.01.027
Stevens, John W, et al. "Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions." Diabetes research and clinical practice vol. 107,3 (2015): 320-31. doi: https://doi.org/10.1016/j.diabres.2015.01.027
Stevens JW, Khunti K, Harvey R, Johnson M, Preston L, Woods HB, Davies M, Goyder E. Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions. Diabetes Res Clin Pract. 2015 Mar;107(3):320-31. doi: 10.1016/j.diabres.2015.01.027. Epub 2015 Jan 21. PMID: 25638454.
Copy Download .nbib Format: NLM
Inhibition of serum and glucocorticoid regulated kinases by GSK650394 reduced infarct size in early cerebral ischemia-reperfusion with decreased BBB disruption.

Neuroscience letters

Chi OZ, Chiricolo A, Liu X, Patel N, Jacinto E, Weiss HR.
PMID: 34332027
Neurosci Lett. 2021 Sep 25;762:136143. doi: 10.1016/j.neulet.2021.136143. Epub 2021 Jul 29.

Blood-brain barrier (BBB) disruption is one of the most important pathological changes following cerebral ischemia-reperfusion. We tested whether inhibition of the serum and glucocorticoid regulated kinase 1 (SGK1) would decrease BBB disruption and contribute to decreasing infarct size in...

Cite
Chi OZ, Chiricolo A, Liu X, et al. Inhibition of serum and glucocorticoid regulated kinases by GSK650394 reduced infarct size in early cerebral ischemia-reperfusion with decreased BBB disruption. Neurosci Lett. 2021;762:136143doi: 10.1016/j.neulet.2021.136143.
Chi, O. Z., Chiricolo, A., Liu, X., Patel, N., Jacinto, E., & Weiss, H. R. (2021). Inhibition of serum and glucocorticoid regulated kinases by GSK650394 reduced infarct size in early cerebral ischemia-reperfusion with decreased BBB disruption. Neuroscience letters, 762136143. https://doi.org/10.1016/j.neulet.2021.136143
Chi, Oak Z, et al. "Inhibition of serum and glucocorticoid regulated kinases by GSK650394 reduced infarct size in early cerebral ischemia-reperfusion with decreased BBB disruption." Neuroscience letters vol. 762 (2021): 136143. doi: https://doi.org/10.1016/j.neulet.2021.136143
Chi OZ, Chiricolo A, Liu X, Patel N, Jacinto E, Weiss HR. Inhibition of serum and glucocorticoid regulated kinases by GSK650394 reduced infarct size in early cerebral ischemia-reperfusion with decreased BBB disruption. Neurosci Lett. 2021 Sep 25;762:136143. doi: 10.1016/j.neulet.2021.136143. Epub 2021 Jul 29. PMID: 34332027; PMCID: PMC8434992.
Copy Download .nbib Format: NLM
Diagnosis and management of food allergy and intolerance in dogs and cats.

Australian veterinary journal

Wills J, Harvey R.
PMID: 7848179
Aust Vet J. 1994 Oct;71(10):322-6. doi: 10.1111/j.1751-0813.1994.tb00907.x.

This paper reviews food allergy and intolerance in dogs and cats. Adverse reactions to ingested food components can affect many systems and can produce signs involving the skin, gastrointestinal tract, respiratory tract and central nervous system, and these clinical...

Cite
Wills J, Harvey R. Diagnosis and management of food allergy and intolerance in dogs and cats. Aust Vet J. 1994;71(10):322-6doi: 10.1111/j.1751-0813.1994.tb00907.x.
Wills, J., & Harvey, R. (1994). Diagnosis and management of food allergy and intolerance in dogs and cats. Australian veterinary journal, 71(10), 322-6. https://doi.org/10.1111/j.1751-0813.1994.tb00907.x
Wills, J, and Harvey, R. "Diagnosis and management of food allergy and intolerance in dogs and cats." Australian veterinary journal vol. 71,10 (1994): 322-6. doi: https://doi.org/10.1111/j.1751-0813.1994.tb00907.x
Wills J, Harvey R. Diagnosis and management of food allergy and intolerance in dogs and cats. Aust Vet J. 1994 Oct;71(10):322-6. doi: 10.1111/j.1751-0813.1994.tb00907.x. PMID: 7848179.
Copy Download .nbib Format: NLM
Vergence compensation during binocularly- and monocularly-evoked horizontal optokinetic nystagmus in the pigmented rat.

Vision research

De'sperati C, Tempia F, Harvey R, Strata P.
PMID: 7863617
Vision Res. 1994 Dec;34(24):3335-45. doi: 10.1016/0042-6989(94)90068-x.

During horizontal optokinetic nystagmus evoked by binocular stimulation in the rat, the slow phases are well-conjugate. The fast phases in the adducting eye are on average about 2 deg greater in amplitude than those of the abducting eye. This...

Cite
De'sperati C, Tempia F, Harvey R, et al. Vergence compensation during binocularly- and monocularly-evoked horizontal optokinetic nystagmus in the pigmented rat. Vision Res. 1994;34(24):3335-45doi: 10.1016/0042-6989(94)90068-x.
De'sperati, C., Tempia, F., Harvey, R., & Strata, P. (1994). Vergence compensation during binocularly- and monocularly-evoked horizontal optokinetic nystagmus in the pigmented rat. Vision research, 34(24), 3335-45. https://doi.org/10.1016/0042-6989(94)90068-x
De'sperati, C, et al. "Vergence compensation during binocularly- and monocularly-evoked horizontal optokinetic nystagmus in the pigmented rat." Vision research vol. 34,24 (1994): 3335-45. doi: https://doi.org/10.1016/0042-6989(94)90068-x
De'sperati C, Tempia F, Harvey R, Strata P. Vergence compensation during binocularly- and monocularly-evoked horizontal optokinetic nystagmus in the pigmented rat. Vision Res. 1994 Dec;34(24):3335-45. doi: 10.1016/0042-6989(94)90068-x. PMID: 7863617.
Copy Download .nbib Format: NLM
Transforming activity of polyoma virus middle-T antigen probed by site-directed mutagenesis.

Nature

Oostra BA, Harvey R, Ely BK, Markham AF, Smith AE.
PMID: 6308461
Nature. 1983 Aug 4-10;304(5925):456-9. doi: 10.1038/304456a0.

The ability of polyoma virus to transform cells results primarily from the action of one of the virus-coded early proteins, called middle-T antigen. Middle-T has an associated tyrosine-specific protein kinase activity that can be measured in vitro and results...

Cite
Oostra BA, Harvey R, Ely BK, et al. Transforming activity of polyoma virus middle-T antigen probed by site-directed mutagenesis. Nature. 1983;304(5925):456-9doi: 10.1038/304456a0.
Oostra, B. A., Harvey, R., Ely, B. K., Markham, A. F., & Smith, A. E. (1983). Transforming activity of polyoma virus middle-T antigen probed by site-directed mutagenesis. Nature, 304(5925), 456-9. https://doi.org/10.1038/304456a0
Oostra, B A, et al. "Transforming activity of polyoma virus middle-T antigen probed by site-directed mutagenesis." Nature vol. 304,5925 (1983): 456-9. doi: https://doi.org/10.1038/304456a0
Oostra BA, Harvey R, Ely BK, Markham AF, Smith AE. Transforming activity of polyoma virus middle-T antigen probed by site-directed mutagenesis. Nature. 1983 Aug 4-10;304(5925):456-9. doi: 10.1038/304456a0. PMID: 6308461.
Copy Download .nbib Format: NLM
The judgement of urines.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Harvey R.
PMID: 9875256
CMAJ. 1998 Dec 15;159(12):1482-4.
Free PMC Article

No abstract available.

Cite
Harvey R. The judgement of urines. CMAJ. 1998;159(12):1482-4
Harvey, R. (1998). The judgement of urines. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 159(12), 1482-4.
Harvey, R. "The judgement of urines." CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne vol. 159,12 (1998): 1482-4.
Harvey R. The judgement of urines. CMAJ. 1998 Dec 15;159(12):1482-4. PMID: 9875256; PMCID: PMC1229894.
Copy Download .nbib Format: NLM
Non-penetrance in a MODY 3 family with a mutation in the hepatic nuclear factor 1alpha gene: implications for predictive testing.

European journal of human genetics : EJHG

de Silva D, Ellard S, Haites N, Harvey R, Hattersley AT, Miedzybrodzka Z, Pearson D.
PMID: 10482964
Eur J Hum Genet. 1999 Sep;7(6):729-32. doi: 10.1038/sj.ejhg.5200358.

The most common cause of maturity-onset diabetes of the young (MODY) is a mutation in the hepatic nuclear factor 1alpha (HNF1alpha) gene (MODY3). We describe a family in which a missense mutation causing a Thr-Ile substitution at codon 620...

Cite
de Silva D, Ellard S, Haites N, et al. Non-penetrance in a MODY 3 family with a mutation in the hepatic nuclear factor 1alpha gene: implications for predictive testing. Eur J Hum Genet. 1999;7(6):729-32doi: 10.1038/sj.ejhg.5200358.
de Silva, D., Ellard, S., Haites, N., Harvey, R., Hattersley, A. T., Miedzybrodzka, Z., & Pearson, D. (1999). Non-penetrance in a MODY 3 family with a mutation in the hepatic nuclear factor 1alpha gene: implications for predictive testing. European journal of human genetics : EJHG, 7(6), 729-32. https://doi.org/10.1038/sj.ejhg.5200358
de Silva, D, et al. "Non-penetrance in a MODY 3 family with a mutation in the hepatic nuclear factor 1alpha gene: implications for predictive testing." European journal of human genetics : EJHG vol. 7,6 (1999): 729-32. doi: https://doi.org/10.1038/sj.ejhg.5200358
de Silva D, Ellard S, Haites N, Harvey R, Hattersley AT, Miedzybrodzka Z, Pearson D. Non-penetrance in a MODY 3 family with a mutation in the hepatic nuclear factor 1alpha gene: implications for predictive testing. Eur J Hum Genet. 1999 Sep;7(6):729-32. doi: 10.1038/sj.ejhg.5200358. PMID: 10482964.
Copy Download .nbib Format: NLM
Showing 721 to 728 of 728 entries